FDA clears first medical device accessory for Apple Watch
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Apple (AAPL) PT Maintained at $215 at Guggenheim; 'Revisiting Services with Upside Potential in AR Apps and Original Programming'
December 1, 2017 6:15 AM ESTGuggenheim maintained its price target on Apple (NASDAQ: AAPL) at $215.00 while maintaining a Buy rating, following a review of the company's Augmented Reality apps and Original Programming initiatives.
Analyst Robert Chira notes a slight increase in estimates, suggesting this iPhone... More
